RS20090036A - Pyrazole derivatives as cytochrom p450 inhibitors - Google Patents

Pyrazole derivatives as cytochrom p450 inhibitors

Info

Publication number
RS20090036A
RS20090036A RSP-2009/0036A RSP20090036A RS20090036A RS 20090036 A RS20090036 A RS 20090036A RS P20090036 A RSP20090036 A RS P20090036A RS 20090036 A RS20090036 A RS 20090036A
Authority
RS
Serbia
Prior art keywords
cytochrom
inhibitors
pyrazole derivatives
methods
solvates
Prior art date
Application number
RSP-2009/0036A
Other languages
English (en)
Inventor
Simon Paul PLANKER
Scott Channing Sutton
Rongliang Chen
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of RS20090036A publication Critical patent/RS20090036A/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Ovaj pronalazak obezbeđuje jedinjenja formule (I), ili njihove farmaceutski prihvatljive soli ili solvate, postupke za njihovu izradu, postupke za njihovu upotrebu i farmaceutske formulacije koje ih sadrže.
RSP-2009/0036A 2006-07-05 2007-06-25 Pyrazole derivatives as cytochrom p450 inhibitors RS20090036A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80659606P 2006-07-05 2006-07-05
US91098807P 2007-04-10 2007-04-10
US94180807P 2007-06-04 2007-06-04
PCT/IB2007/001878 WO2008004096A1 (en) 2006-07-05 2007-06-25 Pyrazole derivatives as cytochrome p450 inhibitors

Publications (1)

Publication Number Publication Date
RS20090036A true RS20090036A (en) 2010-06-30

Family

ID=38515807

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2009/0036A RS20090036A (en) 2006-07-05 2007-06-25 Pyrazole derivatives as cytochrom p450 inhibitors

Country Status (24)

Country Link
US (1) US7919488B2 (sr)
EP (1) EP2046774A1 (sr)
KR (1) KR20090034958A (sr)
CN (1) CN101511812A (sr)
AP (1) AP2009004763A0 (sr)
AR (1) AR062154A1 (sr)
AU (1) AU2007270814B2 (sr)
CA (1) CA2660031A1 (sr)
CO (1) CO6150178A2 (sr)
CR (1) CR10573A (sr)
EA (1) EA200900135A1 (sr)
GT (1) GT200700053A (sr)
IL (1) IL196490A0 (sr)
MA (1) MA30629B1 (sr)
MX (1) MX2009000482A (sr)
NO (1) NO20090346L (sr)
NZ (1) NZ574207A (sr)
PE (1) PE20080998A1 (sr)
RS (1) RS20090036A (sr)
TN (1) TN2009000033A1 (sr)
TW (1) TWI334867B (sr)
UY (1) UY30460A1 (sr)
WO (1) WO2008004096A1 (sr)
ZA (1) ZA200900478B (sr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101534824A (zh) * 2006-11-17 2009-09-16 艾博特公司 作为化学活素受体拮抗剂的氨基吡咯烷
CA2680360A1 (en) * 2007-03-13 2008-09-18 Arete Therapeutics, Inc. 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
JP2011512359A (ja) 2008-02-14 2011-04-21 アミラ ファーマシューティカルズ，インク． プロスタグランジンｄ２受容体のアンタゴニストとしての環式ジアリールエーテル化合物
US8426449B2 (en) 2008-04-02 2013-04-23 Panmira Pharmaceuticals, Llc Aminoalkylphenyl antagonists of prostaglandin D2 receptors
DE102008057343A1 (de) 2008-11-14 2010-05-20 Bayer Schering Pharma Aktiengesellschaft Heterocyclisch substituierte Aryl-Verbindungen und ihre Verwendung
DE102009041242A1 (de) 2009-09-11 2011-12-15 Bayer Schering Pharma Aktiengesellschaft Heterocyclisch substituierte Aryl-Verbindungen und ihre Verwendung
DE102008057344A1 (de) 2008-11-14 2010-05-20 Bayer Schering Pharma Aktiengesellschaft Aminoalkyl-substituierte Aryl-Verbindungen und ihre Verwendung
DE102009041241A1 (de) 2009-09-11 2011-08-04 Bayer Schering Pharma Aktiengesellschaft, 13353 Substituierte Aryl-Verbindungen und ihre Verwendung
DE102008057364A1 (de) 2008-11-14 2010-05-20 Bayer Schering Pharma Aktiengesellschaft Substituierte Aryl-Verbindungen und ihre Verwendung
WO2010057118A2 (en) 2008-11-17 2010-05-20 Amira Pharmaceuticals, Inc. Heterocyclic antagonists of prostaglandin d2 receptors
MX2012015252A (es) 2010-06-30 2013-05-30 Ironwood Pharmaceuticals Inc Estimuladores de sgc.
CN107266433A (zh) 2010-11-09 2017-10-20 铁木医药有限公司 sGC刺激剂
CN104066731B (zh) 2011-12-27 2016-06-15 铁木医药有限公司 可用作sgc刺激剂的2-苄基、3-(嘧啶-2-基)取代的吡唑类
WO2014000178A1 (en) 2012-06-27 2014-01-03 Merck Sharp & Dohme Corp. Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug
CN104540813A (zh) * 2012-06-27 2015-04-22 默沙东公司 磺酰胺衍生物以及使用它们用于改善药物的药物动力学的方法
WO2014194519A1 (en) * 2013-06-07 2014-12-11 Merck Sharp & Dohme Corp. Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug
WO2015070367A1 (en) 2013-11-12 2015-05-21 Merck Sharp & Dohme Corp. Piperidine or piperazine linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug
WO2015070366A1 (en) * 2013-11-12 2015-05-21 Merck Sharp & Dohme Corp. Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug
WO2020163689A1 (en) * 2019-02-08 2020-08-13 University Of Pittsburgh - Of The Commonwealth System Of Higher Education 20-hete formation inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0024795D0 (en) 2000-10-10 2000-11-22 Hoffmann La Roche Pyrazole derivatives for the treatment of viral diseases
DE60201740T2 (de) * 2001-04-05 2005-11-03 Torrent Pharmaceuticals Ltd., Ahmedabad Heterocyclische verbindungen für alterungs und diabetes bedingte vasculare erkrankungen
US7008953B2 (en) * 2003-07-30 2006-03-07 Agouron Pharmaceuticals, Inc. 3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
US7662844B2 (en) * 2004-07-12 2010-02-16 Osi Pharmaceuticals, Inc. Naphthylene derivatives as cytochrome P450 inhibitors
EA014329B1 (ru) 2005-09-23 2010-10-29 Пфайзер Продактс Инк. Пиридинаминосульфонилзамещенные бензамиды в качестве ингибиторов цитохрома р450 3а4 (cyp3a4)

Also Published As

Publication number Publication date
US7919488B2 (en) 2011-04-05
UY30460A1 (es) 2008-02-29
AU2007270814A1 (en) 2008-01-10
AR062154A1 (es) 2008-10-22
TW200811159A (en) 2008-03-01
WO2008004096A1 (en) 2008-01-10
CO6150178A2 (es) 2010-04-20
CN101511812A (zh) 2009-08-19
AP2009004763A0 (en) 2009-02-28
NZ574207A (en) 2010-10-29
NO20090346L (no) 2009-02-19
EP2046774A1 (en) 2009-04-15
TN2009000033A1 (fr) 2010-08-19
GT200700053A (es) 2009-08-03
MA30629B1 (fr) 2009-08-03
CA2660031A1 (en) 2008-01-10
ZA200900478B (en) 2010-04-28
MX2009000482A (es) 2009-01-27
TWI334867B (en) 2010-12-21
IL196490A0 (en) 2011-07-31
PE20080998A1 (es) 2008-08-15
AU2007270814B2 (en) 2011-07-14
CR10573A (es) 2009-02-12
KR20090034958A (ko) 2009-04-08
US20080021011A1 (en) 2008-01-24
EA200900135A1 (ru) 2009-06-30

Similar Documents

Publication Publication Date Title
RS20090036A (en) Pyrazole derivatives as cytochrom p450 inhibitors
UA94964C2 (ru) Производные 5-замещенного хиназолинона, композиция, которая их содержит, и их применение
IL260127B (en) mek inhibitors and methods of using them
HK1120506A1 (en) Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)
MY148634A (en) Pyridazinone derivatives
UA97976C2 (ru) 4'-о-замещенные изоиндолиновые производные и содержащие их композиции, и способы их применения
NO20081554L (no) Isoindollmidforbindelser og sammensetninger omfattende samme, og anvendelse derav
TN2009000446A1 (en) P70 s6 kinase inhibitors
MX2011011136A (es) Eteres diarilicos.
MX2010001754A (es) Derivados de azepina como inhibidores de gamma secretasa.
WO2007087548A3 (en) Chemical compounds
MX2009008540A (es) Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina.
WO2008027542A3 (en) 5-substituted isoindoline compounds
MX2010007553A (es) Derivados de azopirazolona biciclo-sustituidos, procedimiento de preparacion y uso farmaceutico de los mismos.
MX2013007892A (es) Derivados de fenetilsulfona isoindolina y su uso.
WO2008004100A9 (en) Therapeutic compounds
WO2008039894A3 (en) Atorvastatin pharmaceutical compositions
WO2008011539A3 (en) Anesthetic compounds
UA94759C2 (ru) Производные пиразола как ингибиторы цитохрома p450
UA95250C2 (ru) Пиридинаминосульфонил-замещенные бензамиды как ингибиторы цитохром р450 3а4 (cyp4503a4)